June 12, 2020 / 1:38 PM / 25 days ago

BRIEF-Tasly Pharmaceutical Plans To Sell Stake In Marketing Firm, To Invest In Immunotech Biopharm's Hong Kong IPO

June 12 (Reuters) - Tasly Pharmaceutical:

* SAYS IT AND SIX INDIRECTLY-OWNED COMPANIES PLAN TO SELL A COMBINED 99.94% STAKE IN MARKETING FIRM FOR 1.49 BILLION YUAN ($210.72 million)

* SAYS IT PLANS TO INVEST $10.0 MILLION IN IMMUNOTECH BIOPHARM LTD'S INITIAL SHARE PUBLIC OFFERING IN HONG KONG STOCK EXCHANGE Source text in Chinese: bit.ly/2zpHg8P; bit.ly/3hw4J9M Further company coverage: ($1 = 7.0711 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below